Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Trials Show Efficacy of PARP-Targeted Agent in Prostate Cancer

December 22nd 2014

Drugs that inhibit the DNA repair enzyme poly(ADP-ribose) polymerase (PARP) have been shown to be effective in treating ovarian, breast, and prostate cancers in patients with inherited BRCA mutations. In broadening the therapeutic scope of PARP inhibitors beyond germline BRCA-mutated cancers.

Studies Find That Blood and Body Fats Drive Prostate Cancer

December 20th 2014

Fats in blood and on the body increase men's prostate cancer risk, two studies have found.

Multiparametric MRI Could Reduce Overdetection and Overtreatment in Prostate Cancer

December 20th 2014

The use of multiparametric MRI in diagnosing and treating prostate cancer was explored in November during a continuing medical education course offered at the annual meeting of LUGPA

Final Thoughts on Improving Prostate Cancer Care

December 17th 2014

Integrating a Medical Oncologist Into Urology Practices

December 17th 2014

Combination Strategies Explored in CRPC

December 17th 2014

Integrating Radium-223 Into Clinical Practice

December 17th 2014

Providing Optimal Care for Prostate Cancer

December 17th 2014

Data: The New Currency in Healthcare Improvement

December 17th 2014

Integrating Dispensing Pharmacy Services Into a Urology Group

December 17th 2014

Multiparametric MRI Biopsies: Poised for Widespread Adoption?

December 17th 2014

Multiparametric MRI for Detecting Prostate Cancer

December 17th 2014

Analyzing CTCs Using Next-Generation Sequencing

December 5th 2014

Next-Generation of CTC Technology

December 5th 2014

Clinical Utility of Circulating Tumor Cells

December 5th 2014

Latest News & Insight: December 5, 2014

December 5th 2014

Pre-Chemo Abiraterone Extends Survival in CRPC

November 21st 2014

ADT With GnRH Antagonists in Prostate Cancer

November 21st 2014

Upcoming Advances for GU Cancers

November 21st 2014

Latest News & Insight: November 20, 2014

November 21st 2014